BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27521167)

  • 1. Community pharmacy owners' views of star ratings and performance measurement: In-depth interviews.
    Teeter BS; Fox BI; Garza KB; Harris SG; Nau DP; Owensby JK; Westrick SC
    J Am Pharm Assoc (2003); 2016; 56(5):549-54. PubMed ID: 27521167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare star ratings: stakeholder proceedings on community pharmacy and managed care partnerships in quality.
    Academy of Managed Care Pharmacy ; American Pharmacists Association
    J Am Pharm Assoc (2003); 2014; 54(3):228-40. PubMed ID: 24770440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient perceptions of a pharmacy star rating model.
    Warholak TL; Patel M; Rosenthal M; West-Strum D; Ettienne EB; Nunlee-Bland G; Nau D; Hincapie AL
    J Am Pharm Assoc (2003); 2017; 57(3):311-317. PubMed ID: 28285064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of think-aloud protocols to identify a decision-making process of community pharmacists aimed at improving CMS Star Ratings scores.
    George DL; Smith MJ; Draugalis JR; Tolma EL; Keast SL; Wilson JB
    Res Social Adm Pharm; 2018 Mar; 14(3):262-268. PubMed ID: 28356212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community pharmacists' beliefs regarding improvement of Star Ratings scores using the Theory of Planned Behavior.
    George DL; Smith MJ; Draugalis JR; Tolma EL; Keast SL; Wilson JB
    J Am Pharm Assoc (2003); 2018; 58(1):21-29. PubMed ID: 29074146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Environmental Factors on Differences in Quality of Medication Use: An Insight for the Medicare Star Rating System.
    Desai V; Nau D; Conklin M; Heaton PC
    J Manag Care Spec Pharm; 2016 Jul; 22(7):779-86. PubMed ID: 27348278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges of standardized continuous quality improvement programs in community pharmacies: the case of SafetyNET-Rx.
    Boyle TA; MacKinnon NJ; Mahaffey T; Duggan K; Dow N
    Res Social Adm Pharm; 2012; 8(6):499-508. PubMed ID: 22421196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
    Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
    Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of strategic planning education on attitudes and perceptions of independent community pharmacy owners/managers.
    Harrison DL
    J Am Pharm Assoc (2003); 2007; 47(5):599-604. PubMed ID: 17848349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategic planning by independent community pharmacies.
    Harrison DL
    J Am Pharm Assoc (2003); 2005; 45(6):726-33. PubMed ID: 16381420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Just a 'romantic idea'? A theory-based interview study on medication review implementation with pharmacy owners.
    Michel DE; Tonna AP; Dartsch DC; Weidmann AE
    Int J Clin Pharm; 2023 Apr; 45(2):451-460. PubMed ID: 36639520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Pharmacist-Led, Patient-Centered Program Incorporating Motivational Interviewing for Behavior Change to Improve Adherence Rates and Star Ratings in a Medicare Plan.
    Spears J; Erkens J; Misquitta C; Cutler T; Stebbins M
    J Manag Care Spec Pharm; 2020 Jan; 26(1):35-41. PubMed ID: 31880222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a reimbursed medication review program: Corporate and pharmacy level strategies.
    MacKeigan LD; Ijaz N; Bojarski EA; Dolovich L
    Res Social Adm Pharm; 2017; 13(5):947-958. PubMed ID: 28462792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Describing the patient experience from Yelp reviews of community pharmacies.
    Lester CA; Wang M; Vydiswaran VGV
    J Am Pharm Assoc (2003); 2019; 59(3):349-355. PubMed ID: 31000435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keeping the "continuous" in continuous quality improvement: exploring perceived outcomes of CQI program use in community pharmacy.
    Boyle TA; Bishop AC; Duggan K; Reid C; Mahaffey T; MacKinnon NJ; Mahaffey A
    Res Social Adm Pharm; 2014; 10(1):45-57. PubMed ID: 23528447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of attitudes and perceptions of independent community pharmacy owners/managers on the comprehensiveness of strategic planning.
    Harrison DL
    J Am Pharm Assoc (2003); 2006; 46(4):459-64. PubMed ID: 16913389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of an adherence intervention program on patient adherence and star ratings measures in a large community pharmacy chain.
    Johnson K; Kirby J; Kayse A; Brookhart A; Frede S; Hincapie A
    J Am Pharm Assoc (2003); 2020; 60(4):e70-e78. PubMed ID: 32229088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementing an integrated care management program in community pharmacies: A focus on medication management services.
    Smith MG; Ferreri SP; Brown P; Wines K; Shea CM; Pfeiffenberger TM
    J Am Pharm Assoc (2003); 2017; 57(2):229-235.e1. PubMed ID: 28173993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Medicare Part D on independent and chain community pharmacies in rural Illinois--A qualitative study.
    Bono JD; Crawford SY
    Res Social Adm Pharm; 2010 Jun; 6(2):110-20. PubMed ID: 20511110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Funding for change: New Zealand pharmacists' views on, and experiences of, the community pharmacy services agreement.
    Kinsey H; Scahill S; Bye L; Harrison J
    Int J Pharm Pract; 2016 Dec; 24(6):379-389. PubMed ID: 27121985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.